Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [11313]

Large differences in cancer survival between European countries still remain despite major improvements in cancer diagnosis and treatment

Large differences in cancer survival between European countries still remain despite major improvements in cancer...

ERA-NET on Translational Cancer Research: Call for Proposals

ERA-NET on Translational Cancer Research: Call for Proposals

NCRI 2013: Funding for cancer research increases by over 60 per cent in 10 years

NCRI 2013: Funding for cancer research increases by over 60 per cent in 10 years

Europe’s health policies ‘must change’ with stakeholders leaving their ‘comfort zones’

Europe’s health policies ‘must change’ with stakeholders leaving their ‘comfort zones’

ECC 2013: The State of Oncology 2013 - a new report draws attention on disparities in cancer care

ECC 2013: The State of Oncology 2013 - a new report draws attention on disparities in cancer care

ECC 2013: New approaches to testing cancer drugs needed

ECC 2013: New approaches to testing cancer drugs needed

Phase III START2 trial for tecemotide in stage III non-small cell lung cancer

Phase III START2 trial for tecemotide in stage III non-small cell lung cancer

CRT pioneer fund, BACIT and Sareum enter agreement to fund development of drugs for pancreatic, bowel and lung cancers

CRT pioneer fund, BACIT and Sareum enter agreement to fund development of drugs for pancreatic, bowel and lung...

ICR comments on UK Science and Technology Committee report on clinical trials

ICR comments on UK Science and Technology Committee report on clinical trials

Cancer Research Technology and Teva Pharmaceuticals form R&D alliance for cancer DNA damage response drugs

Cancer Research Technology and Teva Pharmaceuticals form R&D alliance for cancer DNA damage response drugs

More from ecancer